To further explore the correlation between disease progression and RBP4 levels in patients with HCV, we assessed the r between circulating RBP4 levels and several clinical parameters, including HCV RNA levels, fibrosis measurements, homeostasis model assessment for insulin resistance (HOMA-IR), and levels of AST and ALT (Figure 3). The gene discussed is RBP4; the disease is Insulin resistance.